文献速递白血病

HOX11基因过表达与急性B淋巴细胞白血病复发相关

HOX11 gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2025-08-05

该研究纳入2019至2024年间在广东省治疗的209例B-ALL患者,初诊时取骨髓RNA用RQ-PCR检测基因,分析HOX11过表达与临床特征、基因改变及无进展生存(PFS)的关系。42例(20.1%)复发,26例(12.4%)HOX11过表达;HOX11过表达组复发率更高、白细胞计数更低,且为影响PFS的独立危险因素(p=0.041)。

要点

  • 209例B-ALL中42例(20.1%)复发,26例(12.4%)HOX11过表达。
  • HOX11过表达组TP53伴随率23.07%,低表达组8.7%(p<0.05)。
  • HOX11过表达组与KMT2A::AFF1组复发率更高(p<0.05)。

核心结论

  • 研究首次显示HOX11过表达与复发性B-ALL相关。

研究设计与样本

  • 纳入2019至2024年在广东省治疗的209例B-ALL患者,初诊时取骨髓RNA用RQ-PCR进行基因检测,并分析临床资料。

主要发现

  • 209例B-ALL患者中42例(20.1%)复发,26例(12.4%)HOX11过表达,其中10例复发。
  • HOX11过表达组TP53伴随率为23.07%,HOX11低表达组为8.7%(p<0.05)。
  • Logistic回归显示HOX11过表达组白细胞计数更低、复发率更高(p<0.05)。
  • PFS分析显示HOX11过表达组和KMT2A::AFF1组与更高的疾病复发相关(p<0.05)。
  • Cox回归分析显示HOX11是影响PFS的独立危险因素(p=0.041)。

关键数值与推荐

  • 209例中复发42例(20.1%),HOX11过表达26例(12.4%),其中复发10例。
  • HOX11过表达组TP53伴随率23.07% vs HOX11低表达组8.7%(p<0.05)。
  • HOX11过表达组与KMT2A::AFF1组复发率更高(p<0.05)。
  • HOX11影响PFS的Cox回归p=0.041。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This research aimed to elucidate the association of Homeo Box 11 (HOX11) gene overexpression with refractory acute B-cell lymphoblastic leukaemia (B-ALL). In this investigation, 209 patients with B-ALL, who were treated in Guangdong Province between 2019 and 2024, were included. At the initial diagnosis, the RNA was obtained from bone marrow for genetic testing via Real-time Quantitative Polymerase Chain Reaction (RQ-PCR). Furthermore, the clinical data were acquired and the association of HOX11 with these clinical features and gene alterations was analysed. Finally, the relationship between gene alterations and progression-free survival (PFS) was analysed. Of the 209 B-ALL patients, 42 (20.1%) had recurrent disease. Twenty-six (12.4%) had HOX11 overexpression, of which 10 had recurrent disease. Furthermore, the HOX11 overexpression patients indicated TP53 concomitant of 23.07%, whereas the HOX11 low-expression patients showed TP53 concomitant of 8.7% (p < 0.05). Logistic regression indicated lower WBC counts and higher recurrence rates in the HOX11 overexpression group (p < 0.05). PFS analysis indicated that the HOX11 overexpression group and KMT2A::AFF1 group were associated with higher disease recurrence (p < 0.05). Cox regression analysis showed that HOX11 was an independent risk factor affecting PFS (p = 0.041). These findings are the first to demonstrate an association between HOX11 overexpression and recurrent B-ALL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Zhong M, Yin C, Wang Y, et al. HOX11 gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia. Br J Haematol. 2025. PMID: 40762137. doi:10.1111/bjh.70071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。